International Program Committee

Here is the 2020 Summit International Program Committee.

Shahin GHARAKHANIAN, MD, DPH
[Principal & Program Chair]

Co-founder in 2017, Boston-Paris Biotechnology Summit® Principal & Chief Medical Officer Shahin Gharakhanian MD Consulting LLC

CIC: Cambridge Innovation Center Cambridge MA, USA

Christophe ARBET-ENGELS, MD, PhD, MBA

CMO: Chief Medical Officer, MILLENDO Therapeutics, French Foreign Trade Advisor (CCEF)

Boston MA, USA

Pierre COURTILLE, Pharmacist, MBA

Vice-President, France Biotech, Chief Commercial Officer & VP Business Development, ABIVAX

Paris, France

Mark De ROSCH, PhD, FRACP

Chief Regulatory Officer, EPIZYME Inc.

Cambridge MA, USA

Nicola LA MONICA, PhD

Senior Director, Infectious Diseases Scientific Innovation @ Janssen Pharmaceutical Companies of Johnson & Johnson

Boston MA, USA

Cecile LE CAMUS, MD

Executive Director, Medical Lead Cystic Fibrosis, VERTEX Pharmaceuticals

Boston MA, USA

Imran NASRULLAH, PhD

VicePresident & Head, Open Innovation Center North America – East at Bayer Pharmaceuticals

Cambridge MA, USA

Tibor NEMES, MBA

PRESIDENT, Stallergenes Greer Americas

Boston MA, USA

Marc FILERMAN

CEO, German Accelerator Life Sciences

Cambridge MA, USA

Frederick E. "Rick" PIERCE II

CEO & President, SanaRx Bio-therapeutics, Inc. Founder & Principal, FEP Capital Advisors

Cambridge MA, New York, USA; Beijing & Shanghai, China

Heather A. STEINMAN, PhD, MBA

Vice President for Business Development & Executive Director of Technology Transfer at The WISTAR Institute

Philadelphia PA, USA

Milos TODOROVIC, PhD

Trade Commissioner – Life Sciences, Consulate General of Canada

Boston MA, USA